C Vanchieri. Show Affiliations »
Abstract
Entities: Chemical
Mesh: See more » Angiogenesis Inhibitors/therapeutic useBrain Neoplasms/drug therapyChelating Agents/therapeutic useClinical Trials as TopicCombined Modality TherapyCopper/adverse effectsCopper/bloodCopper/metabolismGlioblastoma/drug therapyHumansMolybdenum/therapeutic useNeoplasms/bloodNeoplasms/drug therapyNeoplasms/pathologyNeovascularization, Pathologic/chemically inducedNeovascularization, Pathologic/drug therapyPenicillamine/therapeutic use
Substances: See more » Angiogenesis InhibitorsChelating AgentsCopperMolybdenumtetrathiomolybdatePenicillamine
Year: 2000 PMID: 10922401 DOI: 10.1093/jnci/92.15.1202
Source DB: PubMed Journal: J Natl Cancer Inst ISSN: 0027-8874 Impact factor: 13.506